Skip to main content
Dec. 20, 2018

Kuraray and Merck extend collaboration to deliver pharmaceutical grades of PVA

Hattersheim: December 20, 2018. Kuraray today announced that it has extended its global collaboration with Merck to exclusively supply PVA for excipient use in solid, liquid and semi-solid formulated drug compounds.

Kuraray and Merck extend collaboration to deliver pharmaceutical grades of PVA


Kuraray and Merck extend collaboration to deliver pharmaceutical grades of PVA

Due to its physical and chemical properties, Kuraray Poval™ can be used in a wide-ranging field of applications and is a remarkably versatile polymer platform for use in developing drug formulations.

Contact or Request a Sample

Do you have any questions, need technical support or would like to request a sample?

Contact POVAL